BackBetta Pharmaceuticals , Ltd. Overview

Betta Pharmaceuticals , Ltd. Receivables

Latest receivables for 300558.SZ: $680M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$683.43M
↑ 88.31% YoYΔ $320.50M vs prior year quarter

Peer trimmed avg / median

Loading

Betta Pharmaceuticals , Ltd. Receivables History

Loading

Betta Pharmaceuticals , Ltd. vs. peers: Receivables Comparison

Loading

Betta Pharmaceuticals , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Betta Pharmaceuticals , Ltd. (300558.SZ) FAQ

Betta Pharmaceuticals , Ltd. (300558.SZ) currently reports a receivables of $680M as of September 2026. That compares with $360M in the prior-year period — up 88.3% year over year. Use the charts on this page to explore Betta Pharmaceuticals , Ltd.'s receivables history and peer comparisons.

Betta Pharmaceuticals , Ltd.'s receivables increased from $360M to $680M — a 88.3% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Betta Pharmaceuticals , Ltd. reported $680M in receivables as of September 2026. That compares with $360M in the prior-year period — up 88.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $680M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Betta Pharmaceuticals , Ltd., and consider following 300558.SZ for alerts when major investors trade the stock.